TREATMENT OF OSTEOPOROSIS OF AGEING WITH 1α-HYDROXYCHOLECALCIFEROL
- 13 December 1975
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 306 (7946), 1168-1171
- https://doi.org/10.1016/s0140-6736(75)92656-2
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Short-term effects of 1,25-dihydroxycholecalciferol on disordered calcium metabolism of renal failureAmerican Journal Of Medicine, 1974
- ACTION OF 1α-HYDROXY VITAMIN D3 ON CALCIUM ABSORPTION AND BONE RESORPTION IN MANThe Lancet, 1974
- EFFECTS OF 1,25-DIHYDROXYCHOLECALCIFEROL ON CALCIUM ABSORPTION, MUSCLE WEAKNESS, AND BONE DISEASE IN CHRONIC RENAL FAILUREThe Lancet, 1974
- FREQUENCY OF OSTEOMALACIA AND OSTEOPOROSIS IN FRACTURES OF THE PROXIMAL FEMURThe Lancet, 1974
- 1α-Hydroxy Derivative of Vitamin D 3 : A Highly Potent Analog of 1α,25-Dihydroxyvitamin D 3Science, 1973
- Action of 1,25-Dihydroxycholecalciferol, a Potent, Kidney-Produced Metabolite of Vitamin D3, in Uremic ManNew England Journal of Medicine, 1972
- COMPETITIVE PROTEIN-BINDING RADIOASSAY FOR 25-HYDROXYCHOLECALCIFEROL1Journal of Clinical Endocrinology & Metabolism, 1971
- Unique Biosynthesis by Kidney of a Biologically Active Vitamin D MetaboliteNature, 1970
- EFFECT OF AGE ON CALCIUM ABSORPTIONThe Lancet, 1970
- “Activation” of vitamin D by the liverJCI Insight, 1969